Aimei Health Technology (NASDAQ:AFJK) Posts Quarterly Earnings Results

Aimei Health Technology (NASDAQ:AFJK) posted its quarterly earnings results on Thursday. The company reported ($0.03) earnings per share (EPS) for the quarter, FiscalAI reports.

Aimei Health Technology Price Performance

AFJK traded up $0.05 on Friday, reaching $12.05. The company’s stock had a trading volume of 1,780 shares, compared to its average volume of 29,542. Aimei Health Technology has a 1 year low of $6.75 and a 1 year high of $130.37. The business’s 50 day moving average is $20.80 and its 200 day moving average is $32.80. The stock has a market cap of $38.20 million, a price-to-earnings ratio of 200.87 and a beta of 0.90.

Institutional Investors Weigh In On Aimei Health Technology

Hedge funds and other institutional investors have recently modified their holdings of the stock. Jane Street Group LLC acquired a new stake in Aimei Health Technology during the fourth quarter worth about $302,000. Geode Capital Management LLC bought a new position in shares of Aimei Health Technology during the fourth quarter valued at approximately $413,000. Quarry LP raised its position in shares of Aimei Health Technology by 6.4% during the 3rd quarter. Quarry LP now owns 167,081 shares of the company’s stock worth $1,891,000 after purchasing an additional 10,000 shares during the period. Finally, Clear Street Group Inc. boosted its position in Aimei Health Technology by 36.5% during the 4th quarter. Clear Street Group Inc. now owns 83,337 shares of the company’s stock valued at $5,334,000 after purchasing an additional 22,294 shares during the period. Institutional investors own 45.58% of the company’s stock.

Analysts Set New Price Targets

Separately, Weiss Ratings restated a “sell (d+)” rating on shares of Aimei Health Technology in a report on Wednesday, June 24th. One research analyst has rated the stock with a Sell rating, According to MarketBeat, Aimei Health Technology has an average rating of “Sell”.

Aimei Health Technology Company Profile

Aimei Health Technology Co, Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors. Aimei Health Technology Co, Ltd was incorporated in 2023 and is based in New York, New York.